A Guide to the Genetics of Psychiatric Disease

Abstract The road to scientific discovery begins with an awareness of what is unknown. Research in science can in some ways be like putting together the pieces of a puzzle without having the benefit of the box—top picture of the completed puzzle. The “picture” in science is an understanding of how nature works in a particular instance, and it takes many separate pieces of the “puzzle” to put this understanding together. These pieces are always of different kinds of data, often obtained using different approaches and techniques. The challenge of the researcher is to picture or hypothesize each of the missing pieces before actually having them in hand, so they can be sought and tested in the laboratory. This “picturing” is actually having a clear idea of what you don't know: having a clear image of the “shape” of the missing piece. This is easy when the puzzle surrounding the missing piece is already in hand, but more difficult with less of it constrained by what is already known. In putting paper puzzles together, the shape of the pieces is not the only limitation that needs to be satisfied. There is also the picture to satisfy, that is, the picture usually has to make sense. In science these constraints can be manifold, and usually the quality of the research is judged by the number of ways a piece of data integrates into and brings together the rest of the puzzle. The multidimensionality of scientific questions makes it virtually essential that as many different pieces of the puzzle as possible be obtained. The more that is not known about the puzzle, the more pieces you need. Thus it is with the genetics of psychiatric diseases. In this guide, we will explore as many of the domains of the genetic puzzle as we are aware of. We will learn a bit of the language of each and how they fit into the puzzle with at least one anecdote to serve as an example. Mapping unknown territory is always a process, but we hope this guide will increase the reader's awareness of what is unknown.

[1]  E. Gershon,et al.  Closing in on Genes for Manic-Depressive Illness and Schizophrenia , 1998, Neuropsychopharmacology.

[2]  M. Tsuang,et al.  Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs. , 2000, Drug and alcohol dependence.

[3]  M. Egan,et al.  Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.

[4]  Eric R. Kandel,et al.  Identification of a Signaling Network in Lateral Nucleus of Amygdala Important for Inhibiting Memory Specifically Related to Learned Fear , 2002, Cell.

[5]  M. Stein,et al.  Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study. , 2002, The American journal of psychiatry.

[6]  M. Stein,et al.  Gender differences in susceptibility to posttraumatic stress disorder. , 2000, Behaviour research and therapy.

[7]  Daniel R Weinberger,et al.  Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia , 2003, Neuropsychopharmacology.

[8]  Wendy Raskind,et al.  Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorder , 2001, Psychiatry Research.

[9]  M. Caron,et al.  Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration. , 1996, Biochemistry.

[10]  M. Adams,et al.  The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families , 1995, Nature Genetics.

[11]  E. Winzeler,et al.  Genomics, gene expression and DNA arrays , 2000, Nature.

[12]  S. L. Wong,et al.  A Map of the Interactome Network of the Metazoan C. elegans , 2004, Science.

[13]  S. Southwick,et al.  A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. , 2002, Archives of general psychiatry.

[14]  M. Wolfe.  APP, Notch, and presenilin: molecular pieces in the puzzle of Alzheimer's disease. , 2002, International immunopharmacology.

[15]  D. Nickerson,et al.  Variation is the spice of life , 2001, Nature Genetics.

[16]  Michael F Egan,et al.  Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague‐Dawley rats , 2003, Synapse.

[17]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[18]  N. Risch,et al.  Will the genomics revolution revolutionize psychiatry? , 2003, The American journal of psychiatry.

[19]  J. Kelsoe,et al.  Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder , 2003, Molecular Psychiatry.

[20]  A B Niculescu,et al.  The human genome: genetic testing and animal models. , 2001, The American journal of psychiatry.

[21]  A. Shalev,et al.  Genetics of Posttraumatic Stress Disorder , 2003, CNS Spectrums.

[22]  L. Bierut,et al.  Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. , 2001, The American journal of psychiatry.

[23]  S. R. Nash,et al.  Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases (*) , 1996, The Journal of Biological Chemistry.

[24]  R. Hauger,et al.  GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization. , 2002, Biochemical and biophysical research communications.

[25]  Deborah A. Nickerson,et al.  SNPing in the human genome , 2004, RECOMB.

[26]  D. Weinberger,et al.  Neonatal Damage of the Ventral Hippocampus Impairs Working Memory in the Rat , 2002, Neuropsychopharmacology.

[27]  Robert C. Thompson,et al.  The “chip” as a specific genetic tool , 2000, Biological Psychiatry.

[28]  J. Davidson,et al.  A family study of chronic post-traumatic stress disorder following rape trauma. , 1998, Journal of psychiatric research.

[29]  M. Groudine,et al.  Controlling the double helix , 2003, Nature.

[30]  R. Ozawa,et al.  A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Huda Akil,et al.  Gene chips and arrays revealed: a primer on their power and their uses , 1999, Biological Psychiatry.

[32]  Marc G. Caron,et al.  G Protein-coupled Receptor Kinase 3 (GRK3) Gene Disruption Leads to Loss of Odorant Receptor Desensitization* , 1997, The Journal of Biological Chemistry.

[33]  D. Thakker,et al.  Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between μ and ORL1 receptors following prolonged agonist exposure , 2002, Neuropharmacology.

[34]  E. Birney,et al.  Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs , 2002, Nature.

[35]  J. Callicott,et al.  Brain imaging as an approach to phenotype characterization for genetic studies of schizophrenia. , 2003, Methods in molecular medicine.

[36]  V. Morales,et al.  Chromatin structure and dynamics: functional implications. , 2001, Biochimie.

[37]  E. Pennisi.  Human genome. A low number wins the GeneSweep Pool. , 2003, Science.

[38]  L. Murri,et al.  Causative and susceptibility genes for Alzheimer’s disease: a review , 2003, Brain Research Bulletin.

[39]  K H Buetow,et al.  A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). , 1994, Science.

[40]  Fred Winston,et al.  Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene , 2004, Nature.

[41]  K. Standifer,et al.  Desensitization of alpha 2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by beta 2-adrenoceptor-dependent GRK3 up-regulation. , 2003, British journal of pharmacology.

[42]  A. Meyer-Lindenberg,et al.  Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia , 2002, Nature Neuroscience.

[43]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[44]  K. Krishnan,et al.  Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype. , 2002, American journal of medical genetics.

[45]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[46]  K. Standifer,et al.  Desensitization of α2A‐adrenoceptor signalling by modest levels of adrenaline is facilitated by β2‐adrenoceptor‐dependent GRK3 up‐regulation , 2003 .

[47]  J. Mann,et al.  Substance Abuse Disorder and Major Depression are Associated with the Human 5-HT1B Receptor Gene (HTR1B) G861C Polymorphism , 2003, Neuropsychopharmacology.

[48]  J. Breitner,et al.  Genes and recent developments in the epidemiology of Alzheimer's disease and related dementia. , 1995, Epidemiologic reviews.

[49]  D. Haussler,et al.  Integration of cytogenetic landmarks into the draft sequence of the human genome , 2001, Nature.

[50]  J. Kelsoe.  Arguments for the genetic basis of the bipolar spectrum. , 2003, Journal of affective disorders.